|
ZC3HAV1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.57209999998675E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.69770000011138E-07 |
| Normal-vs-Stage2 |
6.33799999999463E-05 |
| Normal-vs-Stage3 |
2.83069999995611E-07 |
| Normal-vs-Stage4 |
3.89339999999905E-05 |
| Stage1-vs-Stage2 |
3.839400E-01 |
| Stage1-vs-Stage3 |
2.837600E-01 |
| Stage1-vs-Stage4 |
5.847400E-01 |
| Stage2-vs-Stage3 |
9.296400E-01 |
| Stage2-vs-Stage4 |
7.689000E-01 |
| Stage3-vs-Stage4 |
7.942600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.93469999995888E-06 |
| Normal-vs-AfricanAmerican |
5.238900E-03 |
| Normal-vs-Asian |
5.210600E-04 |
| Caucasian-vs-AfricanAmerican |
3.905800E-01 |
| Caucasian-vs-Asian |
8.223800E-01 |
| AfricanAmerican-vs-Asian |
5.476400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68886999999396E-05 |
| Normal-vs-Female |
2.17550000003452E-06 |
| Male-vs-Female |
6.266000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.11949999999939E-05 |
| Normal-vs-Age(41-60Yrs) |
7.48499999758678E-08 |
| Normal-vs-Age(61-80Yrs) |
4.64380000009257E-07 |
| Normal-vs-Age(81-100Yrs) |
3.580200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.077400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.597700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.445000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.030400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.328600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.631000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.271600E-01 |
| Classical-VS-Follicular |
7.7144000000029E-05 |
| Classical-VS-Other |
1.159600E-01 |
| Classical-VS-Normal |
2.034200E-04 |
| Tall-VS-Follicular |
2.268800E-01 |
| Tall-VS-Other |
3.684600E-01 |
| Tall-VS-Normal |
1.422060E-04 |
| Follicular-VS-Other |
8.517800E-01 |
| Follicular-VS-Normal |
8.77329997539533E-09 |
| Other-VS-Normal |
8.817700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.09469999998169E-06 |
| Normal-vs-N1 |
2.48119999990415E-07 |
| N0-vs-N1 |
1.633570E-01 |
|
|
